US FDA to create new Drug Safety Oversight Board

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2005年 / 1039卷 / 1期

关键词：

Health Professional; Human Service; Medium Release; Communication Channel; Safety Issue;

D O I：

10.2165/00128415-200510390-00008

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] FDA enhances oversight of postmarket drug safety
[J]. Reactions Weekly, 2012, 1400 (1) : 2 - 2
[2] US FDA reports new steps in drug safety
[J]. Reactions Weekly, 2007, 1138 (1) : 3 - 3
[3] The US FDA requires a “new vision of drug safety”
[J]. Reactions Weekly, 2006, 1126 (1) : 3 - 3
[4] New board to improve internal oversight, consumer communication of drug safety issues
不详
[J]. FORMULARY, 2005, 40 (05) : 167 - 167
[5] Update on the Office of Drug Safety at the US FDA
[J]. Reactions Weekly, 2004, 1015 (1) : 3 - 4
[6] The Food and Drug Administration's Drug Safety Oversight Board: An Evolving Paradigm for Clinical Input on Drug Safety Topics
Grandinetti, C. A.
Osborne, S. F.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (02) : 269 - 274
[7] SAFETY BOARD HIT IN OVERSIGHT REPORT
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2011, 89 (08) : 26 - 26
[8] US FDA enhancing postmarketing drug safety surveillance
[J]. Reactions Weekly, 2019, 1780 (1) : 3 - 3
[9] Report on Drug Safety and the US FDA by the Institute of Medicine
Anthony W. Fox
[J]. International Journal of Pharmaceutical Medicine, 2006, 20 (5) : 289 - 291
[10] US FDA 2009 drug safety warnings analysed
[J]. Reactions Weekly, 2012, 1388 (1) : 4 - 4

← 1 2 3 4 5 →